• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围产期感染艾滋病毒的青少年和青年的生长发育及身体组成:一项系统评价和荟萃分析

Growth and body composition of adolescents and young adults with perinatal HIV infection: a systematic review and meta-analysis.

作者信息

Costa Priscila R F, Guimarães Nathalia S, Lira Carlos R N, Leite Luana O, de Cássia Ribeiro da Silva Rita, Barreto Maurício L, Paixão Enny S

机构信息

Department of Science Nutrition, Federal University of Bahia, 32 Araujo Pinho Avenue, Salvador, 40.110-907, Brazil.

Post-Graduation Program in Food, Nutrition and Health, Federal University of Bahia, Salvador, Brazil.

出版信息

BMC Public Health. 2025 Feb 21;25(1):717. doi: 10.1186/s12889-025-21838-w.

DOI:10.1186/s12889-025-21838-w
PMID:39984871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11843769/
Abstract

INTRODUCTION

Approximately 1.3 million pregnancies are exposed to HIV perinatally each year, with transmission rates ranging from 4 to 21%, despite 85% antiretroviral therapy (ART) coverage among pregnant women. While ART has significantly reduced mother-to-child transmission, recent studies indicate an increased risk of chronic conditions among perinatally HIV-infected youth. There is a critical need for further research on the growth and health of these populations to inform effective health interventions. Therefore, the aim of this study is to critically evaluate observational research assessing the growth and body composition of perinatally HIV-infected adolescents and young adults.

METHODS

We conducted a systematic review using the MEDLINE (by PubMed), Embase, Central (by Cochrane Library), Latin American and Caribbean Health Science Information (LILACS) and Web of Science databases. The initial search was conducted on November 24, 2022, and updated on June 3, 2024. We included cohort studies that evaluated perinatally HIV-infected adolescents (aged 10 to 19 years) and young adults (aged 20 to 24 years). A meta-analysis was performed to estimate the prevalence of stunting (HAZ < -2) and underweight (BAZ < -2). Additionally, we conducted meta-analyses for the mean values of HAZ and BAZ in the population after the follow-up period, as well as for the mean change in HAZ and BAZ post-follow-up.

RESULTS

Our search strategy retrieved 11,017 documents. After excluding duplicates, we analyzed 9,273 titles and abstracts. A full-text review of the remaining 87 records was conducted. Following the updated search, we identified 6 publications from 4 studies, resulting in a total of 14 studies and 16 publications. Nine studies focused exclusively on adolescents, while three evaluated both children and adolescents, and three included both adolescents and young adults. We estimated a prevalence of stunting at 26% (95% CI: 0.23-0.29) and underweight at 14% (95% CI: 0.12-0.17). In this population, the mean HAZ was -1.58 (95% CI: -1.90; -1.27), and the mean BAZ was -0.34 (95% CI: -0.61; -0.06). Additionally, we identified an increase of 0.55 (95% CI: 0.07; 1.03) in mean HAZ and 0.12 (95% CI: -0.56; 0.79) in mean BAZ after the follow-up period.

CONCLUSIONS

Our study highlights significant growth and body composition challenges among perinatally HIV-infected adolescents and young adults, with concerning rates of stunting and underweight. Although there was a modest increase in height-for-age, persistent challenges in achieving optimal growth remain. The slight improvement in BMI is insufficient to fully address underweight concerns. The limited number of studies and their inherent limitations restrict the ability to draw consistent conclusions regarding the effects and magnitude of exposure on anthropometric outcomes. Further research is needed to better elucidate these relationships.

TRIAL REGISTRATION

CRD42022372837.

摘要

引言

每年约有130万例妊娠在围产期暴露于艾滋病毒,尽管孕妇抗逆转录病毒疗法(ART)的覆盖率达85%,但传播率仍在4%至21%之间。虽然抗逆转录病毒疗法显著降低了母婴传播率,但最近的研究表明,围产期感染艾滋病毒的青少年患慢性病的风险有所增加。迫切需要对这些人群的生长发育和健康状况进行进一步研究,为有效的健康干预措施提供依据。因此,本研究的目的是严格评估观察性研究,以评估围产期感染艾滋病毒的青少年和青年的生长发育和身体成分。

方法

我们使用MEDLINE(通过PubMed)、Embase、Central(通过Cochrane图书馆)、拉丁美洲和加勒比健康科学信息库(LILACS)以及科学网数据库进行了系统综述。初始检索于2022年11月24日进行,并于2024年6月3日更新。我们纳入了评估围产期感染艾滋病毒的青少年(10至19岁)和青年(20至24岁)的队列研究。进行荟萃分析以估计发育迟缓(身高别年龄Z评分[HAZ]<-2)和体重不足(体重别年龄Z评分[BAZ]<-2)的患病率。此外,我们对随访期后人群中HAZ和BAZ的平均值,以及随访后HAZ和BAZ的平均变化进行了荟萃分析。

结果

我们的检索策略检索到11,017篇文献。排除重复文献后,我们分析了9,273篇标题和摘要。对其余87篇记录进行了全文审查。在更新检索后,我们从4项研究中确定了6篇出版物,最终共有14项研究和16篇出版物。9项研究专门针对青少年,3项研究评估了儿童和青少年,3项研究纳入了青少年和青年。我们估计发育迟缓的患病率为26%(95%置信区间:0.23 - 0.29),体重不足的患病率为14%(95%置信区间:0.12 - 0.17)。在该人群中,平均HAZ为-1.58(95%置信区间:-1.90;-1.27),平均BAZ为-0.34(95%置信区间:-0.61;-0.06)。此外,我们发现随访期后平均HAZ增加了0.55(95%置信区间:0.07;1.03),平均BAZ增加了0.十二(95%置信区间:-0.56;0.79)。

结论

我们的研究突出了围产期感染艾滋病毒的青少年和青年在生长发育和身体成分方面面临的重大挑战,发育迟缓和体重不足的发生率令人担忧。尽管年龄别身高有适度增加,但在实现最佳生长方面仍存在持续挑战。体重指数的轻微改善不足以完全解决体重不足问题。研究数量有限及其固有局限性限制了我们就暴露对人体测量结果的影响和程度得出一致结论的能力。需要进一步研究以更好地阐明这些关系。

试验注册

CRD42022372837

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/5f23c5080f56/12889_2025_21838_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/4874b24fe55b/12889_2025_21838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/0469cfecce25/12889_2025_21838_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/e23dca767496/12889_2025_21838_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/3486bad507b3/12889_2025_21838_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/bf13381810f4/12889_2025_21838_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/57cfcfca3627/12889_2025_21838_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/5f23c5080f56/12889_2025_21838_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/4874b24fe55b/12889_2025_21838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/0469cfecce25/12889_2025_21838_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/e23dca767496/12889_2025_21838_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/3486bad507b3/12889_2025_21838_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/bf13381810f4/12889_2025_21838_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/57cfcfca3627/12889_2025_21838_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11843769/5f23c5080f56/12889_2025_21838_Fig7_HTML.jpg

相似文献

1
Growth and body composition of adolescents and young adults with perinatal HIV infection: a systematic review and meta-analysis.围产期感染艾滋病毒的青少年和青年的生长发育及身体组成:一项系统评价和荟萃分析
BMC Public Health. 2025 Feb 21;25(1):717. doi: 10.1186/s12889-025-21838-w.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Growth improvement following antiretroviral therapy initiation in children with perinatally-acquired HIV diagnosed in older childhood in Zimbabwe: a prospective cohort study.在津巴布韦,对诊断为儿童期获得性 HIV 的较大年龄儿童启动抗逆转录病毒治疗后,其生长情况得到改善:一项前瞻性队列研究。
BMC Pediatr. 2022 Jul 25;22(1):446. doi: 10.1186/s12887-022-03466-0.
4
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
5
Associations of linear growth with body composition of perinatally HIV-infected African adolescents.围产期感染艾滋病毒的非洲青少年线性生长与身体成分的关联。
Br J Nutr. 2024 Dec 28;132(12):1593-1601. doi: 10.1017/S000711452400134X. Epub 2024 Nov 11.
6
Growth and the pubertal growth spurt in South African adolescents living with perinatally-acquired HIV infection.南非感染艾滋病毒的青春期前儿童的生长和青春期生长突增。
PLoS One. 2022 Jan 25;17(1):e0262816. doi: 10.1371/journal.pone.0262816. eCollection 2022.
7
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
8
Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration.围生期感染 HIV 的青少年的生长迟缓及生长速度:男性和女性的不同演变。来自 IeDEA 全球儿科合作的多区域分析。
J Int AIDS Soc. 2019 Nov;22(11):e25412. doi: 10.1002/jia2.25412.
9
Prevalence of malnutrition among HIV-infected children in Central and West-African HIV-care programmes supported by the Growing Up Programme in 2011: a cross-sectional study.2011年“成长计划”支持的中非和西非艾滋病毒护理项目中受艾滋病毒感染儿童的营养不良患病率:一项横断面研究。
BMC Infect Dis. 2015 May 26;15:216. doi: 10.1186/s12879-015-0952-6.
10
Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.在IeDEA西非儿科队列中,抗逆转录病毒治疗起始年龄对HIV感染儿童头24个月内追赶生长的影响。
Pediatr Infect Dis J. 2015 Jul;34(7):e159-68. doi: 10.1097/INF.0000000000000734.

本文引用的文献

1
Longitudinal changes in mitochondrial-associated measures and insulin resistance in youth with perinatally-acquired HIV in the U.S.美国围生期感染 HIV 的青少年中线粒体相关指标和胰岛素抵抗的纵向变化
Mitochondrion. 2024 Sep;78:101936. doi: 10.1016/j.mito.2024.101936. Epub 2024 Jul 14.
2
Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America.在北美,经母婴垂直传播感染 HIV 的年轻成年人中非艾滋病定义性共病的发病率。
AIDS. 2024 Jul 15;38(9):1366-1374. doi: 10.1097/QAD.0000000000003892. Epub 2024 Mar 19.
3
Growth Profiles of Children and Adolescents Living with and without Perinatal HIV Infection in Southern Africa: A Secondary Analysis of Cohort Data.
南部非洲围生期 HIV 感染儿童和青少年的生长发育情况:队列数据的二次分析。
Nutrients. 2023 Oct 28;15(21):4589. doi: 10.3390/nu15214589.
4
Global variations in pubertal growth spurts in adolescents living with perinatal HIV.全球范围内,围生期感染 HIV 的青少年青春期生长突增存在差异。
AIDS. 2023 Aug 1;37(10):1603-1615. doi: 10.1097/QAD.0000000000003602. Epub 2023 May 17.
5
Biomarkers of Growth Faltering and Neurodevelopmental Delay in Children who are HIV-Exposed but Uninfected: A Systematic Review.HIV 暴露但未感染儿童生长迟缓及神经发育迟缓的生物标志物:系统评价。
Curr HIV Res. 2023;21(3):172-184. doi: 10.2174/1570162X21666230505152846.
6
Decreased Hepatic Steatosis in South African Adolescents With Perinatal HIV Switching to Dolutegravir-containing Regimens.南非围产期 HIV 感染切换至含多替拉韦方案的青少年患者肝脂肪变性减少。
Pediatr Infect Dis J. 2023 Jul 1;42(7):564-572. doi: 10.1097/INF.0000000000003904. Epub 2023 Mar 14.
7
Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis.阿巴卡韦治疗 HIV 感染婴儿、儿童和青少年的安全性和疗效:系统评价和荟萃分析。
Lancet Child Adolesc Health. 2022 Oct;6(10):692-704. doi: 10.1016/S2352-4642(22)00213-9. Epub 2022 Sep 2.
8
Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis.抗逆转录病毒疗法时代艾滋病毒暴露但未感染儿童的早期神经发育:系统评价和荟萃分析。
Lancet Child Adolesc Health. 2022 Jun;6(6):393-408. doi: 10.1016/S2352-4642(22)00071-2. Epub 2022 Apr 26.
9
Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis.全球范围内,围生期感染 HIV 的青少年的生长和 CD4 模式:CIPHER 队列合作分析。
J Int AIDS Soc. 2022 Mar;25(3):e25871. doi: 10.1002/jia2.25871.
10
Gut Dysfunction Markers Are Associated With Body Composition in Youth Living With Perinatally Acquired Human Immunodeficiency Virus.肠道功能标志物与围生期获得人类免疫缺陷病毒的青少年的身体成分有关。
Clin Infect Dis. 2022 Sep 29;75(6):945-952. doi: 10.1093/cid/ciac053.